Vitamin E may slow functional decline in Alzheimer’s

"I expect some will suggest that the difference in disease stage may matter, but there seems to be a growing and now large consensus that earlier intervention is better, so why would we expect later intervention with an agent of proven nonbenefit earlier to be effective later? I am actually puzzled that anyone is even still studying this."

The study by Dr. Dysken and his colleagues was funded by the Veterans Affairs Cooperative Studies Program. The authors noted multiple financial disclosures, including many with pharmaceutical companies.